CytoSorbents News - CTSO

Company Name	Stock Ticker Symbol	Market	Type
CytoSorbents Corporation	CTSO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.01	1.24%	0.819	16:30:00

Open Price	Low Price	High Price	Close Price	Prev Close
0.80	0.80	0.8199	0.819	0.809

more quote information »

Recent News

Date	Time	Source	Heading
4/26/2024	07:00	GLOBE	CytoSorbents to Report First Quarter 2024 Operating and..
4/17/2024	07:00	GLOBE	STAR-T Pivotal Trial Results to Be Featured as a..
3/06/2024	07:00	GLOBE	CytoSorbents to Report Fiscal 2023 Operating and Financial..
2/08/2024	07:00	GLOBE	CytoSorbents to Present at the TD Cowen 44th Annual Health..
1/17/2024	17:20	EDGAR2	Form 8-K - Current report
1/17/2024	07:15	GLOBE	Groundbreaking Randomized Controlled Trial Reports Excellent..
1/08/2024	15:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/28/2023	16:49	EDGAR2	Form 8-K - Current report
12/28/2023	07:00	GLOBE	CytoSorbents Provides Update on the STAR-T Trial and Reports..
12/15/2023	16:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/13/2023	09:15	EDGAR2	Form 8-K - Current report
12/13/2023	09:15	GLOBE	CytoSorbents Announces Closing of $10.3 Million Registered..
12/11/2023	16:10	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/11/2023	16:10	EDGAR2	Form 8-K - Current report
11/09/2023	16:20	EDGAR2	Form 8-K - Current report
11/09/2023	16:15	GLOBE	CytoSorbents Reports Third Quarter 2023 Financial and..
11/09/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/27/2023	07:00	GLOBE	CytoSorbents to Report Third Quarter 2023 Operating and..
10/05/2023	07:00	GLOBE	CytoSorbents to Present at the 8th Annual Dawson James..
9/27/2023	08:15	EDGAR2	Form 8-K - Current report
9/27/2023	07:00	GLOBE	CytoSorbents Highlights Upcoming Presentations at EACTS..
9/21/2023	09:35	GLOBE	Dawson James Securities Announces October Date for 8th..
9/20/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:30	EDGAR2	Form 8-K - Current report
9/19/2023	07:00	GLOBE	CytoSorbents Announces Kathleen P. Bloch To Resume as..
9/12/2023	16:31	EDGAR2	Form 8-K - Current report
9/11/2023	11:32	GLOBE	CytoSorb with Ex Vivo Organ Perfusion: Transforming the..
9/01/2023	16:43	GLOBE	CytoSorbents Announces Resignation of Chief Financial..
9/01/2023	16:30	EDGAR2	Form 8-K - Current report
8/31/2023	07:00	GLOBE	CytoSorbents Granted Expanded ANVISA Registration to Treat..
8/15/2023	17:57	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/14/2023	07:00	PRNUS	CytoSorbents Completes U.S. and Canadian STAR-T Pivotal..
8/11/2023	17:30	EDGAR2	Form 8-K - Current report
8/08/2023	20:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	16:15	GLOBE	CytoSorbents Reports Second Quarter 2023 Financial and..
8/01/2023	16:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/26/2023	07:00	GLOBE	CytoSorbents to Report Second Quarter 2023 Operating and..
7/19/2023	17:19	EDGAR2	Form 8-K - Current report
7/11/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	20:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..